KSC:005690
Pharmicell Co., Ltd. · KSC · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-07 22:29 UTC
Last close
n/aKRW
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
11.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
35.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
29.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.12Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales2.64x
Its own average over 10 years, 43.21B.
- Profit-14.46x
Its own average over 10 years, -2.79B.
- Free cash flow24.49x
Its own average over 10 years, 1.37B.
- Debt3.29x
Its own average over 9 years, 4.43B.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 24.49 times.
The filed years, as a table
10Each line is 100 at 2014-12-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2014-12-31 | 100.0 | 100.0 |
| 2015-12-31 | 124.9 | 119.6 |
| 2016-12-31 | 138.1 | 121.3 |
| 2017-12-31 | 125.0 | 125.7 |
| 2018-12-31 | 140.7 | 127.5 |
| 2019-12-31 | 161.2 | 129.0 |
| 2020-12-31 | 187.3 | 129.0 |
| 2023-12-31 | 279.0 | 129.1 |
| 2024-12-31 | 321.8 | 129.1 |
| 2025-12-31 | 565.9 | 129.1 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Figures behind the shape
Growth
24.8%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate24.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Five-year EPS growth rate50.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
One-year change in net income537.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Returns on capital
32.6%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity32.6%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets25.6%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
43.9%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin43.9%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin29.6%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin35.4%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin29.5%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
11.8xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings11.8x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
Price to book3.9x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA12.6x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio4.2x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.12safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equity0.12
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio4.92
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage232.6x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score10.94
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
3.0%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Payout ratio3.0%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio28.0x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.